Evidence map›Paper›PMID 37797010›Full record

ArticleScience (New York, N.Y.)2023

PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection.

Daniel Fisch, Moritz M Pfleiderer, Eleni Anastasakou, Gillian M Mackie, Fabian Wendt, Xiangyang Liu, Barbara Clough, Samuel Lara-Reyna, Vesela Encheva, Ambrosius P Snijders and 9 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Identification of miRNA Biomarkers Associated With Staphylococcal Musculoskeletal Infections.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Inducible antibacterial responses in macrophages.Nature reviews. Immunology · 2025
    Review
  17. Targeting viral suppressor of RNAi confers anti-coronaviral activity.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  18. Frontiers in immunology · 2025
    Article
  19. Autophagy and Bacterial infections.Autophagy reports · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 5 countries.

Daniel FischHost-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-8155-0367
Moritz M PfleidererEuropean Molecular Biology Laboratory, 71 Avenue des Martyrs, Grenoble, France.ORCID 0000-0002-2369-5824
Eleni AnastasakouEuropean Molecular Biology Laboratory, 71 Avenue des Martyrs, Grenoble, France.ORCID 0000-0002-0606-3382
Gillian M MackieInstitute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, UK.ORCID 0000-0001-7758-6570
Fabian WendtDepartment of Health Sciences and Technology (D-HEST), ETH Zürich, Institute of Translational Medicine (ITM), Zürich, Switzerland.ORCID 0000-0002-2501-536X
Xiangyang LiuEuropean Molecular Biology Laboratory, 71 Avenue des Martyrs, Grenoble, France.
Barbara CloughInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, UK.ORCID 0000-0002-3235-6170
Samuel Lara-ReynaInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, UK.ORCID 0000-0002-9986-5279
Vesela EnchevaMass Spectrometry and Proteomics Platform, The Francis Crick Institute, London, UK.
Ambrosius P SnijdersMass Spectrometry and Proteomics Platform, The Francis Crick Institute, London, UK.ORCID 0000-0002-5416-8592
Hironori BandoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Masahiro YamamotoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID 0000-0002-6821-2785
Andrew D BeggsInstitute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, UK.ORCID 0000-0003-0784-2967
Jason MercerInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, UK.
Avinash R ShenoyMRC Centre for Molecular Bacteriology and Infection, Department of Infectious Disease, Imperial College London, London, UK.ORCID 0000-0001-6228-9303
Bernd WollscheidDepartment of Health Sciences and Technology (D-HEST), ETH Zürich, Institute of Translational Medicine (ITM), Zürich, Switzerland.ORCID 0000-0002-3923-1610
Kendle M MaslowskiInstitute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, UK.ORCID 0000-0003-1995-5424
Wojtek P GalejEuropean Molecular Biology Laboratory, 71 Avenue des Martyrs, Grenoble, France.ORCID 0000-0001-8859-5229
Eva-Maria FrickelHost-Toxoplasma Interaction Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-9515-3442
The Francis Crick Institute · GBUniversity of Birmingham · GBEuropean Molecular Biology Laboratory · FRSIB Swiss Institute of Bioinformatics · CHThe University of Osaka · JPCancer Research UK Scotland Institute · GB

Funding

Cancer Research UK 27112Medical Research Council FC001076Medical Research Council MR/T029323/1Medical Research Council MR/V030930/1Wellcome Trust FC001076Wellcome Trust FC001999
6 · The paper itself

Abstract

Disruption of cellular activities by pathogen virulence factors can trigger innate immune responses. Interferon-γ (IFN-γ)-inducible antimicrobial factors, such as the guanylate binding proteins (GBPs), promote cell-intrinsic defense by attacking intracellular pathogens and by inducing programmed cell death. Working in human macrophages, we discovered that GBP1 expression in the absence of IFN-γ killed the cells and induced Golgi fragmentation. IFN-γ exposure improved macrophage survival through the activity of the kinase PIM1. PIM1 phosphorylated GBP1, leading to its sequestration by 14-3-3σ, which thereby prevented GBP1 membrane association. During

Indexed as

GTP-Binding ProteinsHost-Pathogen InteractionsImmunity, InnateInterferon-gammaProto-Oncogene Proteins c-pim-1ToxoplasmaToxoplasmosis14-3-3 ProteinsHumansMacrophagesVirulence Factors14-3-3 ProteinsGBP1 protein, humanGTP-Binding ProteinsInterferon-gammaPIM1 protein, humanProto-Oncogene Proteins c-pim-1Virulence Factors

Identifiers

PMID37797010
PMCPMC7615196
OpenAlexW4387392390

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.